Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP962688.RAjbras1jl7epdX-LnqFkCTUZCfHEIeb2wTIS9bM43jj0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP962688.RAjbras1jl7epdX-LnqFkCTUZCfHEIeb2wTIS9bM43jj0130_assertion type Assertion NP962688.RAjbras1jl7epdX-LnqFkCTUZCfHEIeb2wTIS9bM43jj0130_head.
- NP962688.RAjbras1jl7epdX-LnqFkCTUZCfHEIeb2wTIS9bM43jj0130_assertion description "[Here, we demonstrate that for one patient, with the first reported fibroblast growth factor receptor 2 (FGFR2) fusion transcript in ovarian cancer, circulating tumor DNA (ctDNA) is a more sensitive and specific biomarker than CA125, and it can also inform on a candidate therapeutic.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962688.RAjbras1jl7epdX-LnqFkCTUZCfHEIeb2wTIS9bM43jj0130_provenance.
- NP962688.RAjbras1jl7epdX-LnqFkCTUZCfHEIeb2wTIS9bM43jj0130_assertion evidence source_evidence_literature NP962688.RAjbras1jl7epdX-LnqFkCTUZCfHEIeb2wTIS9bM43jj0130_provenance.
- NP962688.RAjbras1jl7epdX-LnqFkCTUZCfHEIeb2wTIS9bM43jj0130_assertion SIO_000772 24563622 NP962688.RAjbras1jl7epdX-LnqFkCTUZCfHEIeb2wTIS9bM43jj0130_provenance.
- NP962688.RAjbras1jl7epdX-LnqFkCTUZCfHEIeb2wTIS9bM43jj0130_assertion wasDerivedFrom befree-20150227 NP962688.RAjbras1jl7epdX-LnqFkCTUZCfHEIeb2wTIS9bM43jj0130_provenance.
- NP962688.RAjbras1jl7epdX-LnqFkCTUZCfHEIeb2wTIS9bM43jj0130_assertion wasGeneratedBy ECO_0000203 NP962688.RAjbras1jl7epdX-LnqFkCTUZCfHEIeb2wTIS9bM43jj0130_provenance.